Cyclization of Motor Cortex Stimulation
The Relationship Between Cyclizing Stimulation and Effective Stimulation During Motor Cortex Stimulation
1 other identifier
interventional
6
1 country
1
Brief Summary
Motor cortex stimulation (MCS) is a form of brain stimulation for patients with neuropathic pain not responsive to medication. An electrode is placed on the surface of the brain and connected to a programmable battery in the chest. The strength of stimulation can be individually adjusted by changing the voltage of stimulation. A too high voltage will produce side effects (e.g. seizures) while a too low voltage will not provide pain control. The aim of this study is to analyze the optimal stimulation timing parameters in patients already implanted with MCS and have received good pain relief. The investigators wish to cyclize on/off MCS in order to save the battery life of the stimulator and also decrease stimulus habituation. The investigators hope to determine these timing parameters while maintaining optimal pain relief.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 4, 2015
CompletedFirst Posted
Study publicly available on registry
June 9, 2015
CompletedStudy Start
First participant enrolled
July 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedOctober 30, 2020
October 1, 2020
1 year
June 4, 2015
October 29, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Pain measured on the Visual Analogue Scale (VAS) with different stimulation settings
At the End of each trial period, typically 14 days after change in stimulation settings
Secondary Outcomes (1)
Quality of Life assessment with the SF-36 questionnaire
At the end of each trial period, typically at 14 days after change in stimulation settings
Other Outcomes (1)
Pain assessment with the McGill pain questionnaire to record impact of pain
At the end of each trial period, typically 14 days after change in stimulation setting
Study Arms (4)
Original Setting- MCS 30 min off/0 min off
ACTIVE COMPARATORPatients at baseline with their original MCS settings: on 30 minutes, off 0 minutes in any single half-hour.
MCS 25 min on/5 min off
EXPERIMENTALPatient MCS settings programmed to: on 25 minutes, off 5 minutes in any single half-hour.
MCS 20 min on/10 min off
EXPERIMENTALPatient MCS settings programmed to: on 20 minutes, off 10 minutes in any single half-hour.
MCS 15 min on/15 min off
EXPERIMENTALPatient MCS settings programmed to: on 15 minutes, off 15 minutes in any single hour.
Interventions
Eligibility Criteria
You may qualify if:
- Adult patient more than 18 years of age
- Chronic neuropathic pain effectively treated with motor cortex stimulation
- Stable medication during the trial
- Willing and able to comply with the study protocol and to return per the follow-up visit schedule and able to provide informed consent.
You may not qualify if:
- Evidence of an active disruptive psychiatric disorder or other known condition significant enough to impact the perception of pain, compliance to intervention and/or ability to evaluate treatment outcome as determined by the investigator
- Technical malfunction of the MCS device
- History of seizures
- Unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Vancouver General Hospital
Vancouver, British Columbia, V5Z 4E3, Canada
Related Publications (4)
Tsubokawa T, Katayama Y, Yamamoto T, Hirayama T, Koyama S. Treatment of thalamic pain by chronic motor cortex stimulation. Pacing Clin Electrophysiol. 1991 Jan;14(1):131-4. doi: 10.1111/j.1540-8159.1991.tb04058.x.
PMID: 1705329RESULTTsubokawa T, Katayama Y, Yamamoto T, Hirayama T, Koyama S. Chronic motor cortex stimulation for the treatment of central pain. Acta Neurochir Suppl (Wien). 1991;52:137-9. doi: 10.1007/978-3-7091-9160-6_37.
PMID: 1792954RESULTPeyron R, Garcia-Larrea L, Deiber MP, Cinotti L, Convers P, Sindou M, Mauguiere F, Laurent B. Electrical stimulation of precentral cortical area in the treatment of central pain: electrophysiological and PET study. Pain. 1995 Sep;62(3):275-286. doi: 10.1016/0304-3959(94)00211-V.
PMID: 8657427RESULTLima MC, Fregni F. Motor cortex stimulation for chronic pain: systematic review and meta-analysis of the literature. Neurology. 2008 Jun 10;70(24):2329-37. doi: 10.1212/01.wnl.0000314649.38527.93.
PMID: 18541887RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor/Neurosurgeon
Study Record Dates
First Submitted
June 4, 2015
First Posted
June 9, 2015
Study Start
July 1, 2015
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
October 30, 2020
Record last verified: 2020-10